What SPECTRUM PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Fischer Seth H.z. | Director | Jul 31 | Disposition to Issuer · D | −54,066 | — | — | 0 |
| Ashton William | Director | Jul 31 | Disposition to Issuer · D | −67,660 | — | — | 0 |
| Vacirca Jeff L | Director | Jul 31 | Disposition to Issuer · D | −295,244 | — | — | 0 |
| Riga Thomas J | See Remarks | Jul 31 | Disposition to Issuer · D | −1,317,694 | — | — | 0 |
| Riga Thomas J | See Remarks | Jul 31 | Disposition to Issuer · D | −204,471 | — | — | 0 |
| Riga Thomas J | See Remarks | Jul 31 | Disposition to Issuer · D | −317,474 | — | — | 0 |
| Bradrick Brittany | Director | Jul 31 | Disposition to Issuer · D | −27,380 | — | — | 0 |
| Brennan Nora | See Remarks | Jul 31 | Disposition to Issuer · D | −463,005 | — | — | 0 |
| Brennan Nora | See Remarks | Jul 31 | Disposition to Issuer · D | −104,823 | — | — | 0 |
| Lim Juhyun | Director | Jul 31 | Disposition to Issuer · D | −29,759 | — | — | 0 |
| McGahan Keith M | See Remarks | Jul 31 | Disposition to Issuer · D | −386,057 | — | — | 0 |
| McGahan Keith M | See Remarks | Jul 31 | Disposition to Issuer · D | −36,770 | — | — | 0 |
| McGahan Keith M | See Remarks | Jul 31 | Disposition to Issuer · D | −195,485 | — | — | 0 |
| Brennan Nora | CFO | May 26 | Open-market sale · S | −32,387 | $1.10 | −$35.5K | 567,828 |
| McGahan Keith M | Chief Legal Officer | Mar 15 | Open-market sale · S | −27,197 | $0.80 | −$21.6K | 189,325 |
| Riga Thomas J | CEO & President | Mar 15 | Open-market sale · S | −31,381 | $0.80 | −$25K | 472,411 |
| McGahan Keith M | Chief Legal Officer | Mar 14 | Open-market sale · S | −15,733 | $0.82 | −$12.9K | 216,522 |
| Riga Thomas J | CEO & President | Mar 14 | Open-market sale · S | −18,153 | $0.82 | −$14.9K | 503,792 |
| McGahan Keith M | Chief Legal Officer | Feb 23 | Open-market sale · S | −18,385 | $0.77 | −$14.2K | 618,312 |
| Riga Thomas J | CEO & President | Feb 22 | Open-market sale · S | −22,402 | $0.77 | −$17.2K | 1,839,639 |
Loading...